Fibroblast Growth Factor-2: A Promising Biomarker for Anxiety and Trauma Disorders
Anxiety and trauma disorders are a significant source of global burden. Although it is clear that there is great heterogeneity in humans’ response to trauma and stress, most research on fear and anxiety has focused on the “average” animal. Increased understanding of the sources of individual differe...
Main Author: | Bronwyn M Graham |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2017-12-01
|
Series: | Journal of Experimental Neuroscience |
Online Access: | https://doi.org/10.1177/1179069517749589 |
Similar Items
-
The relationship between salivary Fibroblast Growth Factor-2 and cortisol reactivity and psychological outcomes prior to and during the COVID-19 pandemic
by: Emma M. Bryant, et al.
Published: (2023-07-01) -
Promises of Fibroblast Growth Factor Receptor–Directed Therapy in Tailored Cancer Treatment
by: Sharmila Fagoonee, et al.
Published: (2020-08-01) -
Fibroblast Growth Factor 9 as a Potential Biomarker for Schizophrenia
by: Xiao-Ling Li, et al.
Published: (2022-04-01) -
Editorial: Pharmacotherapy of Anxiety Disorders: Promises and Pitfalls
by: Amir Garakani, et al.
Published: (2021-03-01) -
The Remission of Social Anxiety Disorder After Trauma: A Case Report of Posttraumatic Growth?
by: Verônica Hühne, et al.
Published: (2021-09-01)